CheckEye
PrivateLast Round
Grant
May 1, 2025
Total Funding Raised
$125,000
Company Overview
CheckEye is a healthtech company that provides an AI-driven platform for the early detection and screening of chronic diseases, such as diabetic retinopathy, using retinal imaging.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Computer Vision, Healthcare Analytics
Business Model
B2B2C
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CheckEye Comparables
Compare CheckEye with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eyenuk | 88% | |
| AEYE Health | 84% | |
| RetinaLyze System A/S | 83% | |
CheckEye Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 1, 2025 | ||||
| Angel | Feb 1, 2025 | ||||
| Grant | Jun 20, 2024 |
CheckEye Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ukraine-Moldova American Enterprise Fund | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 23, 2026
Grew 23% QoQ, from 13 to 16 employees.
CheckEye Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CheckEye's valuation, stock price, and market status.